Home0775 • HKG
add
CK Life Sciences Intl (Holdings) Inc
Previous close
$0.49
Day range
$0.50 - $0.52
Year range
$0.30 - $0.74
Market cap
4.81B HKD
Avg Volume
6.57M
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
In the news
Financials
Income Statement
Revenue
Net income
| (HKD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 1.32B | 2.20% |
Operating expense | 323.51M | -4.23% |
Net income | 500.50K | -97.29% |
Net profit margin | 0.04 | -97.20% |
Earnings per share | — | — |
EBITDA | 117.12M | 36.03% |
Effective tax rate | 79.96% | — |
Balance Sheet
Total assets
Total liabilities
| (HKD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 562.09M | 11.10% |
Total assets | 10.89B | -1.45% |
Total liabilities | 6.87B | -0.11% |
Total equity | 4.01B | — |
Shares outstanding | 9.61B | — |
Price to book | 1.17 | — |
Return on assets | 1.75% | — |
Return on capital | 1.91% | — |
Cash Flow
Net change in cash
| (HKD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 500.50K | -97.29% |
Cash from operations | 72.70M | 80.63% |
Cash from investing | -47.88M | -484.81% |
Cash from financing | -77.72M | 41.39% |
Net change in cash | -57.56M | 42.02% |
Free cash flow | 35.56M | 91.21% |
About
CK Life Sciences International Inc., or CK Life Sciences, is a subsidiary of CK Hutchison Holdings. It is engaged in research and development, commercialization, marketing and sale of biotechnology products. The chairman is Mr. Victor Li, the elder son of Mr. Li Ka-shing, the chairman of Cheung Kong Holdings.
It was established in 2000 and listed on the Hong Kong Stock Exchange via Growth Enterprise Market in 2002. It was transferred to Main Board of the Hong Kong Stock Exchange in 2008.
CK Life Sciences has operations in Australia, and in 2012 acquired an Australian salt company as part of its expansion into the agricultural sector.
The company divested its Canadian subsidiary WEX Pharmaceuticals to Virios Therapeutics for $100 million in October 2024. Wikipedia
CEO
Founded
2000
Website
Employees
1,968
